StevenWilliamCorsoMD

PubMed

• 2 citations
  Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy.
  Elizabeth K Belcher, Eva Culakova, Nikesha J Gilmore, Sara J Hardy, Amber S Kleckner, Ian R Kleckner, Lianlian Lei, Charles Heckler, Michael B Sohn, Bryan D Thompson, ...> ;Journal of the National Cancer Institute. 2022 May 9
• 68 citations
  SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete res...
  Zeina Nahleh, William E. Barlow, Daniel F. Hayes, Anne F. Schott, Julie R. Gralow, William M. Sikov, E. A. Perez, S. Chennuru, Hamid R. Mirshahidi, S. W. Corso, Danika...> ;Breast Cancer Research and Treatment. 2016 Jul 8
• 37 citations
  Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity
  Daniel L. Hertz, Allison M. Deal, Joseph G. Ibrahim, Christine M. Walko, Karen E. Weck, Steven M. Anderson, Gustav Magrinat, Oludamilola Olajide, Susan E. Moore, Rache...> ;The Oncologist. 2016 Jul 1
• 39 citations
  In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
  Daniel L. Hertz, Anna C. Snavely, Howard L. McLeod, Christine M. Walko, Joseph G. Ibrahim, Steven M. Anderson, Karen E. Weck, Gustav Magrinat, Oludamilola Olajide, Sus...> ;British Journal of Clinical Pharmacology. 2015 Nov 1
• 5 citations
  Patients' Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer
  Noel T. Brewer, Jessica T. DeFrank, Wing Keung Chiu, Joseph G. Ibrahim, Christine M. Walko, Peter Rubin, Oludamilola Olajide, Susan G. Moore, Rachael E. Raab, Daniel R...> ;Public Health Genomics. 2014 Jan 1
• 131 citations
  Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
  William J. Irvin, Christine M. Walko, Karen E. Weck, Joseph G. Ibrahim, Wing Keung Chiu, E. Claire Dees, Susan G. Moore, Oludamilola Olajide, Mark L. Graham, Sean Thom...> ;Journal of Clinical Oncology. 2011 Aug 20
• Comprehensive CYP2D6 genotyping in a multiracial population shows differences in allele frequencies between races.
  Irvin WJ, Weck KE, Walko CM, Chiu WK, Rubin P, Olajide OA, Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Anderson SM, Friedman KJ, Dees EC, Flockhart D, Peppe...> ;J. Clin. Oncol.. 2011-05-20
• Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer.
  Brewer NT, Walko CM, Chiu WK, Dressler LG, Yuen A, Rubin P, Olajide OA, Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Peppercorn JM, McLeod HL, Carey LA, Irvi...> ;J. Clin. Oncol.. 2011-05-20
• Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations.
  Ganzinelli, M., Mariani, P., Cattaneo, D., Fossati, R., Fruscio, R., Corso, S., Ricci, F., Broggini, M., Damia, G.> ;Eur J Cancer. 2011 May
• A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer.
  Vecchione, F., Fruscio, R., Dell'Anna, T., Garbi, A., Garcia Parra, R., Corso, S., Lissoni, A. A.> ;Int J Gynecol Cancer. 2007 Mar 01
• 66 citations
  Phase III Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressa...
  Charles L. Loprinzi, John W. Kugler, Debra L. Barton, Amylou C. Dueck, Loren K. Tschetter, Robert A. Nelimark, Ernie P. Balcueva, Kelli N. Burger, Paul J. Novotny, Mar...> ;Journal of Clinical Oncology. 2007 Jan 20
• Phase III randomized trial to evaluate the use of gabapentin alone vs with continuing an antidepressant in women failing an antidepressant for the treatment of hot fla...
  Loprinzi CL, Kugler JW, Barton DL, Dueck AC, Tschetter LK, Nelimark RA, Balcueva EP, Carlson MD, Duane SF, Corso SW> ;J. Clin. Oncol.. 2006-06-20
• 11 citations
  Paclitaxel/Carboplatin/Etoposide Versus Paclitaxel/Topotecan for Extensive-Stage Small Cell Lung Cancer: A Minnie Pearl Cancer Research Network Randomized, Prospective...
  F. Anthony Greco, D. S. Thompson, Lisa H. Morrissey, Joan B. Erland, Howard A. Burris, David R. Spigel, Geetha Joseph, Steven W. Corso, Ellen Spremulli, John D. Hainsw...> ;The Oncologist. 2005 Oct 1
• Paclitaxel/carboplatin/etoposide (PCE) therapy for advanced poorly differentiated neuroendocrine (PDNE) carcinoma: A Minnie Pearl Cancer Research Network phase II trial.
  Miranda FT, Spigel DR, Hainsworth JD, Thompson DS, Yardley DA, Burris HA, Litchy S, Shrader M, Hon JK, Corso SW, Greco FA> ;J. Clin. Oncol.. 2005-06-01
• Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive stage small cell lung cancer: A Minnie Pearl Cancer Research Network randomized prospective ...
  Thompson DS, Hainsworth JD, Morrissey LH, Erland JB, Burris HA, Joseph G, Corso SW, Spremulli E, Greco FA> ;J. Clin. Oncol.. 2004-07-15
• 337 citations
  Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma
  John D. Hainsworth, Sharlene Litchy, Howard A. Burris, Daniel C. Scullin, Steven W. Corso, Denise A. Yardley, Lisa H. Morrissey, F. Anthony Greco> ;Journal of Clinical Oncology. 2002 Oct 15
• Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.
  Rinaldi, D. A., Burris, H. A., Dorr, F. A., Woodworth, J. R., Kuhn, J. G., Eckardt, J. R., Rodriguez, G., Corso, S. W., Fields, S. M., Langley, C.> ;J Clin Oncol. 1995 Nov
• Join now to see all